Outlook Therapeutics
OTLK
OTLK
76 hedge funds and large institutions have $29.3M invested in Outlook Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 5 closing their positions.
Holders
76
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
27
Reduced
18
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
VF
1
Vista Finance
Clayton,
Missouri
|
$485K |
| 2 |
2
Renaissance Technologies
New York
|
$61K |
| 3 |
3
Millennium Management
New York
|
$162K |
| 4 |
4
Two Sigma Advisers
New York
|
$240K |
| 5 |
5
BlackRock
New York
|
$8.36M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
AQR Capital Management
Greenwich,
Connecticut
| – | – | -52,041 | Closed |
|
|
VF
77
Virtu Financial
New York
| – | – | -21,119 | Closed |
|
|
HF
78
HRT Financial
New York
| – | – | -20,116 | Closed |
|
|
EWM
79
Endurance Wealth Management
Providence,
Rhode Island
| – | – | -15,000 | Closed |
|
80
UBS Group
Zurich,
Switzerland
| – | – | -1,438 | Closed |
|
|
HFS
81
Hantz Financial Services
Southfield,
Michigan
| $0 | 400 | – | – |
|
|
CFGS
82
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|